Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingavirin in Pediatric Patients with Influenza and ARVI
NCT02644018Phase 3Completed
- Sponsor
- Valenta Pharm
- Start
- Jan 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ingavirin in influenza, acute respiratory viral infection (ARVI), sponsored by Valenta Pharm. Started Jan 2016; status: completed.
02
Drugs
Ingavirin
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT02644018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644018.